Portfolio company
Avisi Technologies, Inc.
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops an ultrathin nanotechnology implant designed to lower intraocular pressure for patients with open-angle glaucoma.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aquesys
This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
VisusNano
This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.
G-Metrics
This digital health company develops implantable micro-sensors and monitoring platforms for glaucoma patients and ophthalmologists to manage intraocular pressure.
Rheon Medical SA
This company develops adjustable drainage devices and ocular implants for the surgical treatment of glaucoma in patients.
Envisia
This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.
Bionode
The company develops wearable neuro-modulation devices and gold-trace contact lenses to treat and prevent elevated intraocular pressure in patients with glaucoma.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
